Global Alosetron market is expected to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Alosetron Market Size and Outlook 2025-31

The global Alosetron market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted. United States market for Alosetron is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Alosetron is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Alosetron is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Alosetron players cover Sebela Pharmaceuticals, Amneal, Par Pharmaceutical, West-Ward Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Alosetron Industry Forecast looks at past sales and reviews total world Alosetron sales in 2024, providing a comprehensive analysis by region and market sector of projected Alosetron sales for 2025 through 2031. With Alosetron sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alosetron industry. This Insight Report provides a comprehensive analysis of the global Alosetron landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alosetron portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Alosetron market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alosetron and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alosetron. This report presents a comprehensive overview, market shares, and growth opportunities of Alosetron market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 0.5 mg Tablets &nbsp;&nbsp;&nbsp; 1 mg Tablets Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Drugstore This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Sebela Pharmaceuticals &nbsp;&nbsp;&nbsp; Amneal &nbsp;&nbsp;&nbsp; Par Pharmaceutical &nbsp;&nbsp;&nbsp; West-Ward Pharmaceuticals Key Questions Addressed in this Report What is the 10-year outlook for the global Alosetron market? What factors are driving Alosetron market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Alosetron market opportunities vary by end market size? How does Alosetron break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Alosetron Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Alosetron by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Alosetron by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Alosetron Segment by Type &nbsp;2.2.1 0.5 mg Tablets &nbsp;2.2.2 1 mg Tablets &nbsp;2.3 Alosetron Sales by Type &nbsp;2.3.1 Global Alosetron Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Alosetron Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Alosetron Sale Price by Type (2020-2025) &nbsp;2.4 Alosetron Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Drugstore &nbsp;2.5 Alosetron Sales by Application &nbsp;2.5.1 Global Alosetron Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Alosetron Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Alosetron Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Alosetron Breakdown Data by Company &nbsp;3.1.1 Global Alosetron Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Alosetron Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Alosetron Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Alosetron Revenue by Company (2020-2025) &nbsp;3.2.2 Global Alosetron Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Alosetron Sale Price by Company &nbsp;3.4 Key Manufacturers Alosetron Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Alosetron Product Location Distribution &nbsp;3.4.2 Players Alosetron Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Alosetron by Geographic Region &nbsp;4.1 World Historic Alosetron Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Alosetron Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Alosetron Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Alosetron Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Alosetron Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Alosetron Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Alosetron Sales Growth &nbsp;4.4 APAC Alosetron Sales Growth &nbsp;4.5 Europe Alosetron Sales Growth &nbsp;4.6 Middle East & Africa Alosetron Sales Growth 5 Americas &nbsp;5.1 Americas Alosetron Sales by Country &nbsp;5.1.1 Americas Alosetron Sales by Country (2020-2025) &nbsp;5.1.2 Americas Alosetron Revenue by Country (2020-2025) &nbsp;5.2 Americas Alosetron Sales by Type (2020-2025) &nbsp;5.3 Americas Alosetron Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Alosetron Sales by Region &nbsp;6.1.1 APAC Alosetron Sales by Region (2020-2025) &nbsp;6.1.2 APAC Alosetron Revenue by Region (2020-2025) &nbsp;6.2 APAC Alosetron Sales by Type (2020-2025) &nbsp;6.3 APAC Alosetron Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Alosetron by Country &nbsp;7.1.1 Europe Alosetron Sales by Country (2020-2025) &nbsp;7.1.2 Europe Alosetron Revenue by Country (2020-2025) &nbsp;7.2 Europe Alosetron Sales by Type (2020-2025) &nbsp;7.3 Europe Alosetron Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Alosetron by Country &nbsp;8.1.1 Middle East & Africa Alosetron Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Alosetron Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Alosetron Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Alosetron Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Alosetron &nbsp;10.3 Manufacturing Process Analysis of Alosetron &nbsp;10.4 Industry Chain Structure of Alosetron 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Alosetron Distributors &nbsp;11.3 Alosetron Customer 12 World Forecast Review for Alosetron by Geographic Region &nbsp;12.1 Global Alosetron Market Size Forecast by Region &nbsp;12.1.1 Global Alosetron Forecast by Region (2026-2031) &nbsp;12.1.2 Global Alosetron Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Alosetron Forecast by Type (2026-2031) &nbsp;12.7 Global Alosetron Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Sebela Pharmaceuticals &nbsp;13.1.1 Sebela Pharmaceuticals Company Information &nbsp;13.1.2 Sebela Pharmaceuticals Alosetron Product Portfolios and Specifications &nbsp;13.1.3 Sebela Pharmaceuticals Alosetron Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Sebela Pharmaceuticals Main Business Overview &nbsp;13.1.5 Sebela Pharmaceuticals Latest Developments &nbsp;13.2 Amneal &nbsp;13.2.1 Amneal Company Information &nbsp;13.2.2 Amneal Alosetron Product Portfolios and Specifications &nbsp;13.2.3 Amneal Alosetron Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Amneal Main Business Overview &nbsp;13.2.5 Amneal Latest Developments &nbsp;13.3 Par Pharmaceutical &nbsp;13.3.1 Par Pharmaceutical Company Information &nbsp;13.3.2 Par Pharmaceutical Alosetron Product Portfolios and Specifications &nbsp;13.3.3 Par Pharmaceutical Alosetron Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Par Pharmaceutical Main Business Overview &nbsp;13.3.5 Par Pharmaceutical Latest Developments &nbsp;13.4 West-Ward Pharmaceuticals &nbsp;13.4.1 West-Ward Pharmaceuticals Company Information &nbsp;13.4.2 West-Ward Pharmaceuticals Alosetron Product Portfolios and Specifications &nbsp;13.4.3 West-Ward Pharmaceuticals Alosetron Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 West-Ward Pharmaceuticals Main Business Overview &nbsp;13.4.5 West-Ward Pharmaceuticals Latest Developments 14 Research Findings and Conclusion

Report	Global Alosetron Market Growth 2025-2031
Selected License	Multi ID: LPI25104

Buyer Information

Order Summary